Sana Biotechnology, Inc. (SANA)
3.865
-0.06
(-1.65%)
USD |
NASDAQ |
Aug 31, 16:00
3.92
+0.06
(+1.42%)
After-Hours: 20:00
Sana Biotechnology Cash from Operations (Annual) : -143.83M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -143.83M |
| December 31, 2024 | -223.15M |
| December 31, 2023 | -253.58M |
| December 31, 2022 | -290.05M |
| Date | Value |
|---|---|
| December 31, 2021 | -251.05M |
| December 31, 2020 | -137.98M |
| December 31, 2019 | -85.50M |
| December 31, 2018 | -13.50M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Twist Bioscience Corp. | -47.63M |
| Beam Therapeutics, Inc. | -345.10M |
| Prime Medicine, Inc. | -162.56M |
| Intellia Therapeutics, Inc. | -394.74M |
| Moderna, Inc. | -1.873B |